• About Us
    • Overview
    • Education
    • Mission & History
    • Board of Directors
    • The Campus
    • Careers
  • Our Achievements
    • Overview
    • Cancer
    • Technology
    • Education
    • Our Planet
    • Health & Medicine
    • Physical World
  • Get Involved
    • Overview
    • Partners in Science
    • Estate & Planned Giving
    • Attend an Event
    • Gift Opportunities
  • News & Media
    • Overview
    • News & Media Archive
    • Coronavirus
    • Feature Stories
    • News Releases
    • In The News
    • Video Gallery
    • Ad Campaigns
    • Celebrating Great Minds
  • Blog
  • Contact
  • Donate
Donate
Donate
About Us tri
About Us Overview
  • Education
  • Mission & History
  • Board of Directors
  • The Campus
  • Careers
About Us

Founded in 1944, the American Committee for the Weizmann Institute of Science develops philanthropic support for the Weizmann Institute in Israel, and advances its mission of science for the benefit of humanity.

Our Achievements tri
Our Achievements Overview
  • Cancer
  • Technology
  • Education
  • Our Planet
  • Health & Medicine
  • Physical World
Our Achievements

The Weizmann Institute’s fundamental research has led to discoveries and applications with a major impact on the scientific community and on the quality of life for millions worldwide.

Get Involved tri
Get Involved Overview
  • Partners in Science
  • Estate & Planned Giving
  • Attend an Event
  • Gift Opportunities
Get Involved

Join a community of dedicated people who share the Weizmann Institute’s commitment to shaping a better world through science.

News & Media tri
News & Media Overview
  • News & Media Archive
  • Coronavirus
  • Feature Stories
  • News Releases
  • In The News
  • Video Gallery
  • Ad Campaigns
  • Celebrating Great Minds
News & Media

Learn about the Weizmann Institute’s latest groundbreaking discoveries and the American Committee’s activities across the country.

Blog tri
  • The Curiosity Review
Blog

Popular science for the curious-minded: The Curiosity Review brings discovery to life.

Contact

Search Results

  • SEARCH BY KEYWORD
  • SEARCH BY TAG
View Articles by Tag:
  • View Articles by Tag
  • Algorithims (6)
  • Alternative energy (27)
  • Alzheimers (44)
  • Archaeology (37)
  • Artificial intelligence (20)
  • Astrophysics (108)
  • Autism (22)
  • Awards (119)
  • Bacteria (107)
  • Behavior (9)
  • Biochemistry (101)
  • Biofuel (7)
  • Biology (309)
  • Biomolecular sciences (7)
  • Blood (43)
  • Brain (175)
  • Cancer (163)
  • Cancer treatment (127)
  • Central nervous system (9)
  • Chemistry (78)
  • Children (7)
  • Circadian clock (1)
  • Climate change (73)
  • Clinical trials (40)
  • Collaborations (19)
  • Community (279)
  • Computers (73)
  • Copaxone (12)
  • Coronavirus (7)
  • Culture (359)
  • Diabetes (32)
  • Earth (74)
  • Education (157)
  • Environment (92)
  • Enzymes (29)
  • Evolution (89)
  • Fertility (20)
  • Fungus (4)
  • Genetics (109)
  • Genomics (3)
  • Heart (5)
  • Heart disease (3)
  • Humanity (83)
  • Immune system (149)
  • Immunology (10)
  • Immunotherapy (34)
  • Inflammation (19)
  • Leadership (114)
  • Leukemia (12)
  • Materials (44)
  • Mathematics (62)
  • Medicine (84)
  • Memory (39)
  • Mental health (58)
  • Metabolism (51)
  • Microbiology (2)
  • Microbiome (10)
  • Molecular cell biology (9)
  • Molecular genetics (61)
  • Multiple sclerosis (12)
  • Nanoscience (33)
  • Nature (4)
  • Neurobiology (2)
  • Neuroscience (207)
  • Nutrition (72)
  • Optics (34)
  • Organs (11)
  • Parkinsons (11)
  • Personalized medicine (5)
  • Philanthropy (148)
  • Physics (139)
  • Plants (56)
  • Proteins (96)
  • Quantum computer (3)
  • Quantum physics (2)
  • Quantum theory (34)
  • Robots (8)
  • Security (21)
  • Senses (115)
  • Sensors (8)
  • Smoking (1)
  • Solar power (19)
  • Space (110)
  • Stem cells (49)
  • Technology (206)
  • Vaccine (40)
  • Virus (135)
  • Water (40)
  • Weather (1)
  • Women (115)
  • World hunger (17)
Filter by Time:
  • All
  • Past Day
  • Past Week
  • Past Month
  • Past Year
  • Past Three Years
Clear Filters

40 results for Clinical trials

Early Clinical Trial for ALS Sufferers Shows Biotech Firm ‘On the Right Track’
Early Clinical Trial for ALS Sufferers Shows Biotech Firm ‘On the Right Track’

https://www.weizmann-usa.org/news-media/in-the-news/early-clinical-trial-for-als-sufferers-shows-biotech-firm-on-the-right-track/

Oct 03, 2019... A researcher working in the lab of Kadimastem in Ness Ziona (Hagit Stavinsky)
Kadimastem Ltd., a biotechnology firm that develops cell therapies, said it has received “promising interim results” from a first group of patients treated with its new therapy for amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, a fatal neurodegenerative condition that causes the loss of muscle control.

TAGS: Neuroscience, Stem cells, Clinical trials

Looking for the Genes that Drive Cancer
Looking for the Genes that Drive Cancer

https://www.weizmann-usa.org/news-media/news-releases/looking-for-the-genes-that-drive-cancer/

Dec 01, 2012... Prof. Yardena Samuels of the Weizmann Institute’s Department of Molecular Cell Biology uses the power of DNA sequencing to identify new groups of genetic mutations involved in the deadliest form of skin cancer, melanoma. One of her discoveries, a mutation found in nearly one-fifth of melanoma cases, was particularly encouraging because it is located in a gene already targeted by a drug approved for certain types of breast cancer, and preliminary clinical trials are underway.

TAGS: Genetics, Women, Cancer, Molecular genetics, Cancer treatment, Clinical trials

A New Noninvasive Monitoring Test for Bladder Cancer
A New Noninvasive Monitoring Test for Bladder Cancer

https://www.weizmann-usa.org/news-media/in-the-news/a-new-noninvasive-monitoring-test-for-bladder-cancer/

Jun 20, 2016... Image via Shutterstock.com
The Israeli company Nucleix has developed a simple, inexpensive urine test to monitor bladder cancer, which has the highest lifetime treatment cost per patient of all types of cancer.
Bladder EpiCheck is expected to be available in Europe in the third quarter of 2016, says Nucleix President and Chief Operating Officer Opher Shapira. Right now, the product is undergoing advanced clinical trials in the Netherlands, Germany, Spain and Israel.

TAGS: Community, Cancer treatment, Clinical trials

Teva Pursues First Type 1 Diabetes Treatment Since Insulin
Teva Pursues First Type 1 Diabetes Treatment Since Insulin

https://www.weizmann-usa.org/news-media/in-the-news/teva-pursues-first-type-1-diabetes-treatment-since-insulin/

Dec 20, 2011... Teva Pharmaceutical Industries Ltd., the world’s largest generic-drug maker, is seeking to transform a compound once rejected by Sanofi into the first treatment to succeed insulin for Type 1 diabetes.
The therapy, DiaPep277, is made from a human protein that stops the immune system from destroying the pancreatic beta cells that secrete insulin, a hormone needed to convert sugar, starches and other food into energy. The drug also helps control sugar levels in the blood, a late-stage study showed last month.

TAGS: Medicine, Diabetes, Clinical trials

Unraveling the Mysteries of Science and Disease
Unraveling the Mysteries of Science and Disease

https://www.weizmann-usa.org/news-media/in-the-news/unraveling-the-mysteries-of-science-and-disease/

Feb 23, 2014... PROF. MICHEL REVEL. Photo: JUDY SIEGEL-ITZKOVICH
Six months after his 75th birthday, after teaching generations of young graduate and post-doctoral students at the Weizmann Institute of Science and with a wife, four children and 12 grandchildren, one could expect Prof. Michel Revel to sit back and enjoy life. Yet, the Frenchborn, internationally acclaimed molecular geneticist, who invented a major drug to treat multiple sclerosis used around the world and received the Israel Prize, EMET Prize and other major awards, has his eyes fixed on the future.

TAGS: Biochemistry, Molecular genetics, Stem cells, Multiple sclerosis, Diabetes, Clinical trials

Using Young Cells to Fight Age-Related Macular Degeneration
Using Young Cells to Fight Age-Related Macular Degeneration

https://www.weizmann-usa.org/news-media/in-the-news/using-young-cells-to-fight-age-related-macular-degeneration/

Aug 30, 2016... Image via GeebShot/Shutterstock.com
Age-related macular degeneration (AMD) is a leading cause of blindness in people over age 60. About 90 percent of those with AMD have the “dry” form for which there is no approved therapy.
And so the race is on to find a cure. The potential is huge, as products for treating the much smaller population of those with wet AMD ring up about $5 billion in annual sales.

TAGS: Community, Senses, Stem cells, Clinical trials

Targeting Tumors: A New Strategy for Prostate Cancer Treatment
Targeting Tumors: A New Strategy for Prostate Cancer Treatment

https://www.weizmann-usa.org/news-media/feature-stories/targeting-tumors-a-new-strategy-for-prostate-cancer-treatment/

Mar 02, 2010... Prof. Yoram Salomon (left) and Prof. Avigdor Scherz (right)
By combining three individually innocuous components, Weizmann Institute of Science researchers Prof. Yoram Salomon of the Department of Biological Regulation and Prof. Avigdor Scherz of the Department of Plant Sciences have created a toxic combination that destroys solid tumors. This cancer therapy, which is the result of nearly 20 years of collaboration between the two scientists, is being studied as a frontline treatment for prostate cancer. However, the strategy may work for other types of cancer as well. "In principle, right now, every solid tumor is potentially a target for this treatment," says Prof. Salomon.

TAGS: Technology, Chemistry, Cancer treatment, Clinical trials

Israel Leads in Prostate Cancer Research
Israel Leads in Prostate Cancer Research

https://www.weizmann-usa.org/news-media/video-gallery/israel-leads-in-prostate-cancer-research/

Jun 17, 2016... Reporter Natasha Kirtchuk describes the new prostate cancer treatment developed by the Weizmann Institute's Profs. Avigdor Scherz and Yoram Salomon, along with an extended team of scientists, researchers, oncologists, urologists, clinicians, technicians, and more. The therapy involves no radiation or chemotherapy, takes just 90 minutes to complete...

TAGS: Cancer, Cancer treatment, Clinical trials

Blood Test for Alzheimer's
Blood Test for Alzheimer's

https://www.weizmann-usa.org/news-media/in-the-news/blood-test-for-alzheimer-s/

Feb 04, 2013... A simple blood test could be on the way for diagnosing Alzheimer’s disease. Image via Shutterstock.com*
“Today one of the main weaknesses in the Alzheimer’s area is that patients don’t find out until it’s too late,” says Ilya Budik, CEO of NeuroQuest, an Israeli company developing a novel blood test for early detection of the most common cause of dementia worldwide.
“There are many new therapies under development, and the most successful trials are showing the earlier a patient is treated, the better likelihood of responding to the treatment,” he says.

TAGS: Neuroscience, Immune system, Clinical trials, Alzheimers, Blood

Can the Organ of Life Save Lives?
Can the Organ of Life Save Lives?

https://www.weizmann-usa.org/news-media/in-the-news/can-the-organ-of-life-save-lives/

Oct 20, 2017... Prof. Reuven Or, from the Bone Marrow Transplantation and Cancer Immunotherapy Research Center, speaks with Pluristem CEO Zami Aberman last month. (photo credit:PLURISTEM)
More than 13,000 Americans are diagnosed with myelodysplastic syndromes, a group of blood disorders associated with abnormal blood cell production. The average length of survival depends on the case, but the prognosis is often bad. However, according to Prof. Reuven Or, from the Bone Marrow Transplantation and Cancer Immunotherapy Research Center at Hadassah University Medical Center in Jerusalem, a new method that would prolong survival and improve quality of life for these patients is on the horizon.

TAGS: Biology, Clinical trials, Blood

First 1 2 3 4 Last
Next
SHARE

Our Achievements

Learn more about remarkable Weizmann Institute achievements that are enhancing and transforming our lives.

Learn More

Support Our Flagship Projects

Help us accelerate exciting initiatives in three forward-looking fields: neuroscience, physics, and artificial intelligence.

Donate Now

Newsletter

Get the latest news and breakthroughs from the Weizmann Institute of Science.

About Us
  • Education
  • Mission & History
  • Board of Directors
  • The Campus
  • Careers
Our Achievements
  • Cancer
  • Technology
  • Education
  • Our Planet
  • Health & Medicine
  • Physical World
Get Involved
  • Partners in Science
  • Estate & Planned Giving
  • Attend an Event
  • Gift Opportunities
News & Media Blog: Curiosity Review Donate Now Contact Us
Privacy Policy Gift Acceptance Policy Financial Information

©2023 American Committee for the Weizmann Institute of Science

Charity Navigator

FOR THE FOURTH CONSECUTIVE YEAR

Platinum Transparency 2023